ABEO — Recent News Coverage
All news mentioning ABEO in ESEN's AI-graded feed
News stories with ABEO as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on ABEO. See /coverage/ABEO for the 30-day aggregate.
SEEKINGALPHA.COM
·
2026-08-13
LOW
NEUTRAL
CORR0.15
Abeona Therapeutics: Earnings Sell-Off Could Be A Buy Opportunity (NASDAQ:ABEO)
$ABEO
◈ ESEN AI
Abeona Therapeutics (ABEO) reported Q2 earnings that triggered a near-term selloff, primarily driven by Zevaskyn rollout execution challenges. The market's initial negative reaction reflects disappointment in commercial…
MANILATIMES.NET
·
2026-08-13
LOW
BULLISH
CORR0.42
Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update
$ABEO
◈ ESEN AI
Abeona Therapeutics (ABEO) reported Q2 2026 earnings with ZEVASKYN® revenue reaching $11.4 million, representing 31% sequential growth. This represents a scheduled quarterly earnings disclosure typical of public company…
MANILATIMES.NET
·
2026-08-06
LOW
NEUTRAL
CORR0.05
Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
$ABEO
◈ ESEN AI
ABEO has scheduled a Q2 2026 earnings conference call for August 13, 2026, with financial results to be released beforehand. This is a routine corporate communication that provides visibility into the biotech firm's qua…
MANILATIMES.NET
·
2026-08-04
NEUTRAL
BULLISH
CORR0.42
CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®
$ABEO
◈ ESEN AI
ABEO received a New Technology Add-On Payment (NTAP) designation from CMS for ZEVASKYN®, a regulatory milestone that enables incremental reimbursement for Medicare beneficiaries beyond standard diagnosis-related group (…
EXPLORE OTHER FILTERS